BCI Pharma - Company Review
BCI Pharma - Company ReviewSummary
BCI Pharma (BCI) is a drug development company that offers small molecule drug discovery programs. The company undertakes discovery of small molecule drugs in the field of infectious diseases. It provides research and development consultancy services and chemical libraries for the treatment of viral diseases. BCI’s BiKin 1 is a new kinase inhibitor. The company provides a wide range of consulting services that supports from the early discovery phase to clinical phase. Its consulting services include analysis of screening campaigns, hit confirmation and validation and patent writing, among others. The company also provides contract research services. BCI is headquartered in Grabels, France.
This comprehensive company report of BCI Pharma provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.